2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      SIDT1-dependent absorption in the stomach mediates host uptake of dietary and orally administered microRNAs

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dietary microRNAs have been shown to be absorbed by mammals and regulate host gene expression, but the absorption mechanism remains unknown. Here, we show that SIDT1 expressed on gastric pit cells in the stomach is required for the absorption of dietary microRNAs. SIDT1-deficient mice show reduced basal levels and impaired dynamic absorption of dietary microRNAs. Notably, we identified the stomach as the primary site for dietary microRNA absorption, which is dramatically attenuated in the stomachs of SIDT1-deficient mice. Mechanistic analyses revealed that the uptake of exogenous microRNAs by gastric pit cells is SIDT1 and low-pH dependent. Furthermore, oral administration of plant-derived miR2911 retards liver fibrosis, and this protective effect was abolished in SIDT1-deficient mice. Our findings reveal a major mechanism underlying the absorption of dietary microRNAs, uncover an unexpected role of the stomach and shed light on developing small RNA therapeutics by oral delivery.

          Related collections

          Most cited references49

          • Record: found
          • Abstract: found
          • Article: not found

          The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments.

          Currently, a lack of consensus exists on how best to perform and interpret quantitative real-time PCR (qPCR) experiments. The problem is exacerbated by a lack of sufficient experimental detail in many publications, which impedes a reader's ability to evaluate critically the quality of the results presented or to repeat the experiments. The Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines target the reliability of results to help ensure the integrity of the scientific literature, promote consistency between laboratories, and increase experimental transparency. MIQE is a set of guidelines that describe the minimum information necessary for evaluating qPCR experiments. Included is a checklist to accompany the initial submission of a manuscript to the publisher. By providing all relevant experimental conditions and assay characteristics, reviewers can assess the validity of the protocols used. Full disclosure of all reagents, sequences, and analysis methods is necessary to enable other investigators to reproduce results. MIQE details should be published either in abbreviated form or as an online supplement. Following these guidelines will encourage better experimental practice, allowing more reliable and unequivocal interpretation of qPCR results.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Origins and Mechanisms of miRNAs and siRNAs.

            Over the last decade, approximately 20-30 nucleotide RNA molecules have emerged as critical regulators in the expression and function of eukaryotic genomes. Two primary categories of these small RNAs--short interfering RNAs (siRNAs) and microRNAs (miRNAs)--act in both somatic and germline lineages in a broad range of eukaryotic species to regulate endogenous genes and to defend the genome from invasive nucleic acids. Recent advances have revealed unexpected diversity in their biogenesis pathways and the regulatory mechanisms that they access. Our understanding of siRNA- and miRNA-based regulation has direct implications for fundamental biology as well as disease etiology and treatment.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              mRNA-based therapeutics--developing a new class of drugs.

              In vitro transcribed (IVT) mRNA has recently come into focus as a potential new drug class to deliver genetic information. Such synthetic mRNA can be engineered to transiently express proteins by structurally resembling natural mRNA. Advances in addressing the inherent challenges of this drug class, particularly related to controlling the translational efficacy and immunogenicity of the IVTmRNA, provide the basis for a broad range of potential applications. mRNA-based cancer immunotherapies and infectious disease vaccines have entered clinical development. Meanwhile, emerging novel approaches include in vivo delivery of IVT mRNA to replace or supplement proteins, IVT mRNA-based generation of pluripotent stem cells and genome engineering using IVT mRNA-encoded designer nucleases. This Review provides a comprehensive overview of the current state of mRNA-based drug technologies and their applications, and discusses the key challenges and opportunities in developing these into a new class of drugs.
                Bookmark

                Author and article information

                Contributors
                wangf65@nju.edu.cn
                qpzhang@nju.edu.cn
                cyzhang@nju.edu.cn
                Journal
                Cell Res
                Cell Res
                Cell Research
                Springer Singapore (Singapore )
                1001-0602
                1748-7838
                17 August 2020
                17 August 2020
                March 2021
                : 31
                : 3
                : 247-258
                Affiliations
                [1 ]GRID grid.41156.37, ISNI 0000 0001 2314 964X, Nanjing Drum Tower Hospital Center of Molecular Diagnostic and Therapy, State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, NJU Advanced Institute of Life Sciences (NAILS), NJU Institute of AI Biomedicine and Biotechnology, School of Life Sciences, , Nanjing University, ; Nanjing, Jiangsu 210023 China
                [2 ]GRID grid.41156.37, ISNI 0000 0001 2314 964X, Department of Gastroenterology and Hepatology, Jinling Hospital, , Medical School of Nanjing University, ; Nanjing, Jiangsu 210002 China
                [3 ]GRID grid.41156.37, ISNI 0000 0001 2314 964X, Department of Clinical Laboratory, Jinling Hospital, School of Medicine, , Nanjing University, ; Nanjing, Jiangsu 210002 China
                [4 ]GRID grid.9227.e, ISNI 0000000119573309, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, , Chinese Academy of Sciences, ; Shanghai, 200031 China
                Author information
                http://orcid.org/0000-0002-2013-4191
                http://orcid.org/0000-0002-1834-2119
                http://orcid.org/0000-0002-7329-7162
                http://orcid.org/0000-0002-5166-2974
                Article
                389
                10.1038/s41422-020-0389-3
                8026584
                32801357
                c6c69d0a-a694-4e28-b504-5638414ff2f9
                © The Author(s) 2020

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 7 April 2020
                : 14 July 2020
                Funding
                Funded by: FundRef https://doi.org/10.13039/501100001809, National Natural Science Foundation of China (National Science Foundation of China);
                Award ID: 81250044
                Award ID: 81602697
                Award ID: 81101330
                Award Recipient :
                Funded by: Chinese Science and Technology Major Project of China (2015ZX09102023-003), National Basic Research Program of China (973 Program) (2014CB542300 and 2012CB517603)
                Funded by: National Key Research and Development plan (2018YFA0507100) of Ministry of Science and Technology
                Categories
                Article
                Custom metadata
                © Center for Excellence in Molecular Cell Science, CAS 2021

                Cell biology
                mirnas,rna transport
                Cell biology
                mirnas, rna transport

                Comments

                Comment on this article